Evaluation of the Effectiveness of a Closed-incision Negative-pressure Therapy (Prevena®) on Bilateral Groin Incision (PREVISION)
Primary Purpose
Bilateral Vascular Groin Surgery
Status
Unknown status
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Closed-incision Negative-pressure Therapy - Dry dressing
Sponsored by
About this trial
This is an interventional treatment trial for Bilateral Vascular Groin Surgery
Eligibility Criteria
Inclusion Criteria:
- Person affiliated to a health insurance system
- Person who has received full information on the organization of the research and has signed his or her informed consent
- Person presenting a bilateral vascular groin surgery
- Major person
Exclusion Criteria:
- Person with a known allergy to one of the components of the evaluated product (including: acrylic or silver-based adhesives)
- Person with a contraindication to the product(s) being evaluated
- Non-collaborative or agitated patient
- Patients with hemostasis problems
- Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code:
- Pregnant woman, parturient or breastfeeding mother
- Minor person (not emancipated)
- Adult person subject to a legal protection measure (guardianship, curatorship, protection of justice)
- Adult person unable to consent
- Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1.
Sites / Locations
- Centre Hospitalier Régional Universitaire de NancyRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Prevena (right side) - Dry dressing (left side)
Prevena (left side) - Dry dressing (right side)
Arm Description
Outcomes
Primary Outcome Measures
Wound aspect - major complication
Left and right wound incision are inspected and the presence of major complication are reported.
Major complication :
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
Secondary Outcome Measures
Score of complications
Left and right wound incision are inspected and the presence of major and minor complication are reported. A score of complications is established.
- Major : Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
- Minor : Bruising Hematoma Wound extension
Each complication amount to 1 point on the complication score.
Major complication in different clinical settings
Left and right wound incision are inspected and the presence of major complication are reported.
Major complication :
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
During the analysis, patient are divided into several group depending of the presence or absence of comorbidities.
Wound aspect - major complication (long term)
Left and right wound incision are inspected and the presence of major complication are reported.
Major complication :
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
Full Information
NCT ID
NCT04174183
First Posted
November 14, 2019
Last Updated
May 6, 2020
Sponsor
Central Hospital, Nancy, France
1. Study Identification
Unique Protocol Identification Number
NCT04174183
Brief Title
Evaluation of the Effectiveness of a Closed-incision Negative-pressure Therapy (Prevena®) on Bilateral Groin Incision
Acronym
PREVISION
Official Title
Evaluation of the Effectiveness of a Closed-incision Negative-pressure Therapy (Prevena®) on Bilateral Groin Incision
Study Type
Interventional
2. Study Status
Record Verification Date
October 2019
Overall Recruitment Status
Unknown status
Study Start Date
December 24, 2019 (Actual)
Primary Completion Date
January 2022 (Anticipated)
Study Completion Date
July 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Central Hospital, Nancy, France
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Closed-incision negative-pressure therapy are medical device that are suspected to reduce groin wound complication in vascular surgery. The aim of this study is to compareon on the same patient a Closed-incision negative-pressure therapy (Prevena®, KCI) versus a traditional gauze dressings after a bilateral vascular groin surgery. To do this, each device is applied on one groin incision and the side, left or right, is randomized.
Detailed Description
The prevalence of surgical site infections in groin vascular surgery is 3-44%. The factors causing these infections are well identified: disruption of lymphatic vessels, proximity of genital organs, presence of prosthetic material, etc. The risk of developing an infection of the surgical site is also influenced by the patient's comorbidities and by the surgical context.
Closed-incision negative-pressure therapy are medical device that are suspected to reduce groin wound complication in vascular surgery. The mechanisms of action for negative-pressure therapy include protecting the wound bed, splinting soft tissue, reducing oedema,increasing perfusion and enhancing development of granulation tissue.
Presently, there are no guidelines for the use of this device or not in groin incision and this decision is left to the surgeon's discretion.
The main objective is to demonstrate the superiority of closed-incision negative-pressure therapy over the application of a traditional gauze dressings to reduce the rate of major complications (i.e. requiring an extension of hospitalization time) during bilateral vascular groin surgery. To do this, each device is applied on one groin incision and the side, left or right, is randomized.
The secondary objectives are:
To demonstrate the superiority of closed-incision negative-pressure therapy over the application of a dry dressing in reducing the score of complications (major and minor) during vascular groin surgery. The complication score is the number of complications observed during the consultation conducted on day four after the surgery, among the following:
Major :
Presence of pus
Bloody and/or lymphatic discharge
Disunity
Necrosis
Minor :
5) Bruising 6) Hematoma 7) Wound extension
To compare the rate of major complications between closed-incision negative-pressure therapy and dry dressing application in different clinical settings.
3. To demonstrate the superiority of closed-incision negative-pressure therapy over the application of a dry dressing in reducing the score of complications 2-3 months after surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Bilateral Vascular Groin Surgery
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
84 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Prevena (right side) - Dry dressing (left side)
Arm Type
Experimental
Arm Title
Prevena (left side) - Dry dressing (right side)
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Closed-incision Negative-pressure Therapy - Dry dressing
Intervention Description
A Closed-incision Negative-pressure Therapy is applied on one groin incision - A dry dressing is applied on one groin incision .
Primary Outcome Measure Information:
Title
Wound aspect - major complication
Description
Left and right wound incision are inspected and the presence of major complication are reported.
Major complication :
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
Time Frame
4 days
Secondary Outcome Measure Information:
Title
Score of complications
Description
Left and right wound incision are inspected and the presence of major and minor complication are reported. A score of complications is established.
- Major : Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
- Minor : Bruising Hematoma Wound extension
Each complication amount to 1 point on the complication score.
Time Frame
4-days
Title
Major complication in different clinical settings
Description
Left and right wound incision are inspected and the presence of major complication are reported.
Major complication :
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
During the analysis, patient are divided into several group depending of the presence or absence of comorbidities.
Time Frame
4-days
Title
Wound aspect - major complication (long term)
Description
Left and right wound incision are inspected and the presence of major complication are reported.
Major complication :
Presence of pus Bloody and/or lymphatic discharge Disunity Necrosis
Time Frame
2-3 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Person affiliated to a health insurance system
Person who has received full information on the organization of the research and has signed his or her informed consent
Person presenting a bilateral vascular groin surgery
Major person
Exclusion Criteria:
Person with a known allergy to one of the components of the evaluated product (including: acrylic or silver-based adhesives)
Person with a contraindication to the product(s) being evaluated
Non-collaborative or agitated patient
Patients with hemostasis problems
Persons referred to in Articles L. 1121-5, L. 1121-7 and L1121-8 of the Public Health Code:
Pregnant woman, parturient or breastfeeding mother
Minor person (not emancipated)
Adult person subject to a legal protection measure (guardianship, curatorship, protection of justice)
Adult person unable to consent
Persons deprived of their liberty by a judicial or administrative decision, persons undergoing psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nicla Settembre, M.D
Phone
+33 3 831 543 84
Email
n.settembre@chru-nancy.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nicla Settembre
Organizational Affiliation
Service de chirurgie vasculaire - Centre Hospitalier Régional Universitaire de Nancy - Allée du Morvan - 54511 Vandœuvre-lès-Nancy Cedex
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Hospitalier Régional Universitaire de Nancy
City
Vandoeuvre-lès-Nancy
State/Province
Grand Est
ZIP/Postal Code
54500
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nicla Settembre, M.D.
Phone
+33 3 831 543 84
Email
n.settembre@chru-nancy.fr
First Name & Middle Initial & Last Name & Degree
Nicla Settembre, Dr
12. IPD Sharing Statement
Learn more about this trial
Evaluation of the Effectiveness of a Closed-incision Negative-pressure Therapy (Prevena®) on Bilateral Groin Incision
We'll reach out to this number within 24 hrs